212 related articles for article (PubMed ID: 22609133)
1. The emerging challenge in diabetes: the "metabolic memory".
Ceriello A
Vascul Pharmacol; 2012; 57(5-6):133-8. PubMed ID: 22609133
[TBL] [Abstract][Full Text] [Related]
2. Hypothesis: the "metabolic memory", the new challenge of diabetes.
Ceriello A
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S2-6. PubMed ID: 20115927
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: the 'metabolic memory', the new challenge of diabetes.
Ihnat MA; Thorpe JE; Ceriello A
Diabet Med; 2007 Jun; 24(6):582-6. PubMed ID: 17490424
[TBL] [Abstract][Full Text] [Related]
4. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?
Ceriello A; Ihnat MA; Thorpe JE
J Clin Endocrinol Metab; 2009 Feb; 94(2):410-5. PubMed ID: 19066300
[TBL] [Abstract][Full Text] [Related]
5. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
Chilelli NC; Burlina S; Lapolla A
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes.
Ceriello A
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S15-9. PubMed ID: 20489415
[TBL] [Abstract][Full Text] [Related]
7. The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.
Testa R; Bonfigli AR; Prattichizzo F; La Sala L; De Nigris V; Ceriello A
Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452927
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products.
Remor AP; de Matos FJ; Ghisoni K; da Silva TL; Eidt G; Búrigo M; de Bem AF; Silveira PC; de León A; Sanchez MC; Hohl A; Glaser V; Gonçalves CA; Quincozes-Santos A; Borba Rosa R; Latini A
Biochim Biophys Acta; 2011 Nov; 1812(11):1460-71. PubMed ID: 21767639
[TBL] [Abstract][Full Text] [Related]
9. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.
Yamagishi SI; Nakamura N; Matsui T
J Diabetes; 2017 Feb; 9(2):141-148. PubMed ID: 27556881
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis.
Palmeira CM; Rolo AP; Berthiaume J; Bjork JA; Wallace KB
Toxicol Appl Pharmacol; 2007 Dec; 225(2):214-20. PubMed ID: 17761203
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
Yamagishi S
Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
[TBL] [Abstract][Full Text] [Related]
12. AGE/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential.
Piperi C; Goumenos A; Adamopoulos C; Papavassiliou AG
Int J Biochem Cell Biol; 2015 Mar; 60():197-201. PubMed ID: 25603271
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
[TBL] [Abstract][Full Text] [Related]
14. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
16. The role of "metabolic memory" in the natural history of diabetes mellitus.
Drzewoski J; Kasznicki J; Trojanowski Z
Pol Arch Med Wewn; 2009; 119(7-8):493-500. PubMed ID: 19776690
[TBL] [Abstract][Full Text] [Related]
17. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
Miyata T; Yamamoto M; Izuhara Y
Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders.
Stefano GB; Challenger S; Kream RM
Eur J Nutr; 2016 Dec; 55(8):2339-2345. PubMed ID: 27084094
[TBL] [Abstract][Full Text] [Related]
19. Glycation, carbonyl stress, EAGLEs, and the vascular complications of diabetes.
Lyons TJ
Semin Vasc Med; 2002 May; 2(2):175-89. PubMed ID: 16222609
[TBL] [Abstract][Full Text] [Related]
20. Metabolic memory: implications for diabetic vascular complications.
Cooper ME
Pediatr Diabetes; 2009 Aug; 10(5):343-6. PubMed ID: 19490497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
